rct
2009
High Quality
Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial
Cavalcanti DR, da Silveira FR
Published in Journal of Oral Pathology & Medicine
Methodology
Randomised double-blind placebo-controlled trial of alpha-lipoic acid 600 mg/day for 60 days in burning mouth syndrome.
Key Findings
No significant difference between alpha-lipoic acid and placebo; both groups improved similarly.
Conclusions
Alpha-lipoic acid did not outperform placebo for burning mouth syndrome.
Limitations
Small sample; single centre; short duration.
Supplements Studied
Alpha Lipoic Acid (ALA)
Compound
Alpha-lipoic acid did not outperform placebo in burning mouth syndrome.
Outcomes Measured
Alpha-lipoic acid was no better than placebo for burning mouth pain.
Related Health Concerns
Study Details
Year:2009
Sample Size:38
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.